06.06.2018 • NewsDowDuPontElaine Burridge

DuPont Expands Luxembourg Tyvek Capacity

DuPont Expands Luxembourg Tyvek Capacity
DuPont Expands Luxembourg Tyvek Capacity

DuPont Safety & Construction, part of DowDuPont Specialty Products, is planning to spend more than $400 million to expand capacity for Tyvek nonwoven materials at its plant in Luxembourg.

The project will add a new building and a third operating line at the site with start-up scheduled sometime in 2021. The plant’s capacity was not disclosed.

Rose Lee, president of DuPont Safety & Construction, said global demand for Tyvek continues to grow worldwide in all of its key end-use markets and the expansion plan is a critical step in growing the business and maintaining its leadership position in nonwoven materials.

The company said that industry estimates for potential Tyvek worldwide use amount to several billion dollars. Tyvek, made wholly from high-density polyethylene fibers, has core market segments in building envelope solutions, protective clothing, medical packaging, and graphics and protective packaging.

 

 

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.